Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.9%

2 terminated/withdrawn out of 34 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

12%

4 trials in Phase 3/4

Results Transparency

0 of 20 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1

12(37.5%)

N/A

9(28.1%)

Phase 2

7(21.9%)

Phase 3

3(9.4%)

Phase 4

1(3.1%)

32Total

Phase 1(12)

N/A(9)

Phase 2(7)

Phase 3(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (34)

Showing 20 of 34 trials

NCT04627753Phase 2Recruiting

Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.

Role: collaborator

NCT07467239Not ApplicableRecruiting

A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds

Role: lead

NCT07292779Not ApplicableRecruiting

A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds

Role: lead

NCT06961448Not ApplicableNot Yet Recruiting

A Study in Adults Evaluating Polycaprolactone Microsphere Filler for Treatment of Moderate to Severe Nasolabial Folds

Role: lead

NCT05207514Phase 3Terminated

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Role: lead

NCT06093321Not ApplicableUnknown

A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement

Role: lead

NCT06295172Not ApplicableNot Yet Recruiting

A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement

Role: lead

NCT06402058Not ApplicableNot Yet Recruiting

A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

Role: lead

NCT05300828Completed

Safety of Genexol PM and Carboplatin as First-line Therapy in Ovarian Cancer

Role: collaborator

NCT05645809Not ApplicableUnknown

Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery

Role: lead

NCT03932045Not ApplicableCompleted

A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds

Role: lead

NCT02263495Phase 2Completed

Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer

Role: collaborator

NCT04066335Unknown

Study to Evaluate the Safety of Nanoxel M Inj.

Role: lead

NCT03674060Phase 1Completed

Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers

Role: lead

NCT02982395Phase 3Terminated

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Role: lead

NCT02739633Phase 2Unknown

Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas

Role: lead

NCT03208218Phase 1Completed

Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers

Role: lead

NCT01023347Phase 2Completed

A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer

Role: lead

NCT01276548Phase 2Completed

A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer

Role: lead

NCT00882973Phase 1Completed

Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer

Role: lead